BIO-TECHNE (TECH) Rating Reiterated by Robert W. Baird


's stock had its "buy" rating reissued by investment analysts at Robert W. Baird in a research note issued to investors on Thursday. They currently have a $154.00 price target on the biotechnology company's stock.



from Biotech News